Company intelligence / Profile preview

Cerene Biomedics

Minneapolis, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Cerene Biomedics is a medical technology company developing a novel neuromodulation therapy for the treatment of drug-resistant epilepsy. The company's primary technology is a focal cooling device that aims to terminate seizures by localized thermal regulation of brain tissue. By utilizing thermoelectric cooling, the device provides a non-pharmacological and reversible method to suppress hyperexcitable neuronal circuits. This approach is designed for patients who do not respond to traditional anti-epileptic drugs and may offer a less invasive alternative to resective brain surgery.

Therapeutic areas: Neurology
Modalities: DeviceNeuromodulation
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Cerene Biomedics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerene Biomedics.

Explore the full profile